Please note that these flowcharts and checklists are from the IRB Researcher Manual.

Similar documents
Please note that these flowcharts and checklists are from the IRB Researcher Manual.

Title: Review of Medical Devices Page: 1 of 5 Written by:

2.0 DETERMINING ACTIVITIES THAT QUALIFY as HUMAN RESEARCH or CLINICAL INVESTIGATIONS

Florida State University Policy 7-IRB-

The Children s Hospital of Philadelphia Committees for the Protection of Human Subjects Policies and Procedures Determination of IND/IDE Requirement

The Institutional Review Board (IRB) Manual

Office of Graduate and Professional Studies

Human Research Protection Program Guidance for Human Research Determination

3.1. Overall Principal Investigator (PI), who holds the IDE and/or is the Sponsor

Office of Graduate and Professional Studies

Human Subjects Research Policy Update. Naomi Coll Director of Research Policy and Compliance

HUMAN RESEARCH PROTECTION PROGRAM PLAN

Device research sponsors, whether companies or investigators, are held responsible for meeting the same regulations.

Advocate Health Care Network. Human Research Protection Program. Plan

Human Subjects Protection Program Plan

MOBILE MEDICAL APPLICATIONS REVIEWING FDA GUIDANCE FOR INDUSTRY USE

UC DAVIS OFFICE OF RESEARCH AAHRPP Preparation UC Davis Human Research Part III Investigator Manual. Cindy Gates IRB Administration

Human Research Protection Program. Plan

Human Research Protection Program Plan

Introduction to the FDA. Historical Context. Changes over Time FDA - BE-200 9/23/2004. Copyright C. S. Tritt, Ph.D. 1

IRB APPLICATION OF FDA REGULATIONS Click for Animation

INVESTIGATIONAL DEVICES & DRUGS. What is an IRB to do?

Research: Ethics, Informed Consent, FDA, Off Label Use

Protection of Research Participants: The IRB Process and the Winds of Change

COOPERATIVE RESEARCH AND EXTERNAL INVESTIGATORS

Paths to Market & FDA Product Lifecycle Regulation. Patricia Kaeding Design of Medical Devices University of Minnesota April 14, 2005

Office for Human Subject Protection. University of Rochester

Is FMT A Drug? Lance Shea, M.S., J.D. Washington Square, Suite Connecticut Ave., NW Washington, DC, D

Human Research Protection Program. Plan

USE OF INVESTIGATIONAL DRUGS OR BIOLOGICS IN HUMAN SUBJECTS RESEARCH

Navigating the FDA, and understanding Medical Device Preemption. Special Counsel Foulston Siefkin

Investigator s Handbook

MCW Office of Research Standard Operating Procedure

Tip Sheet 17: Review of Research by the Expedited Procedure

PREP Course 24: Defining the Differences between FDA and OHRP regulations. Presented by: Hallie Kassan Dorean Flores Office of the IRB

Human Research Protection Program Policy

Guidance for Sponsors, Institutional Review Boards, Clinical Investigators and FDA Staff

1 Purpose. 2 Procedure. Title: FDA-Regulated Research. SOP Number: 1301 Effective Date: June 2, Previous Version Dates:

Title: IRB Purpose, Principles and Responsibilities Page: 1 of 5

11.0 FDA-Regulated Research Research Involving Investigational Drugs and Biologics

CANCER CENTER SCIENTIFIC REVIEW COMMITTEE

Research Involving Human Data or Specimens

Index of Frequently Asked Questions

FDA-Regulated Research

Title: Department: Approved by: Director, Human Research Review and Compliance. KEYWORDS: IRB, Institutional Review Board

Is Your Research Involving Human Subjects Eligible for Exemption? John M. Falletta, M.D. Professor of Pediatrics Senior Chairman, DUHS IRB

Investigator-Initiated Research

Administrative Policies VMC #638.1 and Procedures Manual

ELEMENTS OF A DATA MONITORING PLAN

ClinicalTrials.gov Registration Guide

Human Research Participant Protection Program Institutional Review Board (IRB)

ClinicalTrials.gov Registration Guide

UNIVERSITY OF GEORGIA Institutional Review Board

Human Research Protections Program Policies and Standard Operating Procedures

Draft Guidance for Industry, Clinical Laboratories, and FDA Staff. In Vitro Diagnostic Multivariate Index Assays

Radiation - Florida Department of Health Institutional Review Board

UVA Biorepository & Tissue Research Facility (BTRF) Coded-Specimens Guidance

The Revised Common Rule. Ann Johnson, PhD, MPH IRB Director University of Utah

US Special Operations Command Human Research Protection Office

Medical Device Accessories: Defining Accessories and Classification Pathway for New Accessory Types. Draft Guidance for Industry and

Niccolo Machiavelli (1523)

11.0 FDA-Regulated Research Research Involving Investigational Drugs and Biologics

S A I N T M A RY S E M I N A RY O C T O B E R 1 9,

Human Research Protection Program. Investigator Manual

MCW Office of Research Standard Operating Procedure

The Intersection of Genomics Research and the IDE Regulation

Research Involving FDA Regulated Devices Policy 606 Version: 1.1 POLICY

Devices 3/26/2014. Investigational Devices. What is considered a device?

First Global Forum on Medical Devices Bangkok-Thailand, September Regulatory Control of Medical Devices in Tanzania

Bioresearch Monitoring Inspections in Vitro Diagnostics Devices

Pre-Clinical Testing for Devices and Diagnostics

Defining research compliance Protocol review committees Conflicts of interest Export Controls

1 of 5 11/6/2014 3:08 PM

Outline of Discussion

Quality Assurance for the Research Team: Connecting Day-to-Day Operations to a Regulatory Framework

50 SHADES OF GRAY: WHY AND WHEN IS IRB APPROVAL REQUIRED?

13 FDA-Regulated Research

Investigator Manual. Human Subjects Protection Program

Investigator Manual HRP-103

Stanford University IRB Guidance On Data and Tissue Repositories

INSTITUTIONAL REVIEW BOARD Revision: 1.0. Page #: Page 1 of 5 Approved by: Date: Date Effective: Approved by: Date: Date of Revision:

UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE INSTITUTIONAL REVIEW BOARD CONFLICTS OF INTEREST

IDENTIFYING & MANAGING GCP COMPLIANCE RISKS FOR THE PHARMACEUTICAL, BIOTECH & DEVICE INDUSTRIES

FDA Regulatory Environment for Wearables, Implantables, and Other Digital Health Devices

Institutional Review Board Compliance Elizabeth City State University

Proposal Writing. J. Daniel Stanley, MD Dept. of Surgery September 11, 2009

Guidance for IRBs, Clinical Investigators and Sponsors

UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE INSTITUTIONAL REVIEW BOARD CONFLICTS OF INTEREST

POLICY AND PROCEDURE MANUAL

Human Research Protection Program Policy

Application for Conducting Research in Minneapolis Public Schools (MPS)

Maintaining your Investigational Device Exemption (IDE) with the FDA: Keys for Success. Jenna Stump, MS, CCRP Clinical Research Regulatory Specialist

Clinical Research Overview for New Investigators

and Study Initiation

and Study Initiation

HUMAN SUBJECTS RESEARCH PROTOCOLS

Combination Products at US FDA

Clinical Research at MSU

The Role of the IRB in Clinical Trials: What Patients and Families Need to Know. Marjorie A. Speers, Ph.D. Executive Director, WCG Foundation

Effective Date: October 8, 2015 Policy Number: MHC_RP0301. Corporate Director, HRPP Institutional Official, HRPP

Transcription:

Hello Researcher: Please use the following flowcharts and checklists to help you determine when your research may require a review by the Institutional Review Board (IRB). Please note that these flowcharts and checklists are from the IRB Researcher Manual. Other helpful resources may be found on the IRB website- http://www.uccs.edu/osp/research-compliance/researchinvolving-human-subject-irb.html: 1. IRB Researcher Manual 2. A Dozen Tips for a Successful IRB Application 3. Research with Local School Districts 4. IRB Research Summary Instructions (provides guides for sections of the IRB application) 5. IRB Standard Operating Procedures (SOPs) If you have questions about your specific research project, please feel free to contact us at IRB@uccs.edu. We would be happy to help. Sincerely, The Staff of the Office of Sponsored Programs and Research Integrity (719) 255-3903 (voice) (719) 255-3706 (fax) irb@uccs.edu Version 8.23.17 Office of Sponsored Programs and Research Integrity University Office Park (UOP), Suite 202 1420 Austin Bluffs Pkwy Colorado Springs, CO 80918 t 719-255-3321 f 719-255-3706 osp@uccs.edu

Does Your Project Require a UCCS New IRB Application? Will the research involve only secondary or existing data, documents, or biological specimens? (Defined as data that existed before the research is proposed to the IRB. ) Are you collecting information about people? The focus of the project is on methods, policies, procedures, or organizations. Not human subject research. No need to submit an IRB application. Refer to Secondary or Existing Data Decision Tree The focus of the project is on people or their opinions, perceptions, decisions, choices, or how external factors affect them or their environment. Please see Classroom SOP for policies and procedures. Is this a classroom project? Is the sole intent of the project to meet course requirements? The project may lead to publications outside the course (i.e., presentation, thesis, dissertation, etc.) Is the project an oral history, ethnographic, or journalistic piece? Does the project involves stories that may draw broad conclusions about the population, cultures, norms, or practices? (No research hypothesis required) Is this a quality assurance/quality improvement/organizational effectiveness study? Is it to assess, improve, or develop programs or services for an organization? Published materials will not have the intent to form a hypotheses, draw a conclusion, or generalize findings and will be limited to reporting events, situations, or policies only Will the outcome be generalized beyond a specific group, entity, or institution being studied? Not human subject research. No need to submit an IRB application. Outcomes will remain within the organization, programs or services. Project is human subject research. Submit application to IRB office. IRB approval is required prior to the initiation of the study. Contact irb@uccs.edu with questions. Forms available at http://www.uccs.edu/osp/research-compliance/research-involving-human-subject-irb.html#forms

Does Your Research Involving Secondary or Existing Data or Biological Specimens Require Review by UCCS IRB?* Will the data/specimens be about people who may be or are still living?. Materials are from non-living, or data is from deceased persons. Project is not human subject research. No need to submit an IRB application.*. Data is all publicly available Are the specimens (tissue, human cell lines, etc.) obtained from a supply/producer of public use data; or Is all the information about the specimens/data available in the public domain with no password required?. Data is de-identified. Can the data provider link the specimens/data, directly or indirectly, to the identifiable information? Are you requesting FERPA data? Was the intent for the specimens/data to be collected specifically for research through interaction with living persons?. Provider is solely providing specimens/data with no role in research. Can the recipient (PI) link the specimens/data, directly or through a code, to the identifiable information? Project is human subject research. Submit application to IRB office. IRB approval is required prior to the initiation of the study. Contact irb@uccs.edu with questions.** Is the provider of the specimens/data taking part in the recipient s (PI s) research? This could be taking part in the design, conduct or reporting of the research, being listed as a collaborator on research proposals or protocols, or planned sharing of authorship credit. Recipient (PI) and provider are collaborators on the research * If an approval is required to publish, it is a requirement to submit an IRB application. No retroactive approvals will be provided. If a PI is needing a signed agreement in order to obtain data, please contact the Office of Sponsored Programs and Research Integrity (OSPRI) at osp@uccs.edu. OSPRI will negotiate the terms of the agreement on behalf of UCCS. ** Forms available at http://www.uccs.edu/osp/research-compliance/research-involving-human-subject-irb.html#forms

Is your project Research or Quality Assessment/Quality Improvement?* Is this a systematic investigation designed with the intent to contribute to generalizable knowledge (e.g. testing a hypothesis; randomization of subjects; comparison of case vs. control; observational research; comparative effectiveness research; or comparable criteria in alternative research paradigms)? Will the project involve testing an experimental drug, device (including medical software or assays) or biologic? IRB review is likely required. Contact the IRB for guidance IRB review is likely required to address FDA requirements. Contact the IRB for guidance. Will the results of the project be published, presented or disseminated outside the institution conducting it? Is this a multi-site project (e.g. there is a coordinating or lead center, more than one site participating, and/or a study-wide protocol)? Has the project received funding (e.g. federal, industry) to be conducted as a human subjects research study? This project appears to constitute QA/QI. Further IRB review is not required. Ensure that all those associated with the project are aware that it is ongoing.* IRB review is likely required. Contact the IRB for guidance IRB review is likely required. Contact the IRB for guidance. Will the project occur regardless of whether individuals conducting it may benefit professionally from it? Will the results of the project be published, presented or disseminated outside the institution conducting it? The project does not appear to fit the definition of QA/QI. Contact the IRB for guidance. This project appears to constitute QA/QI and does not fit the federal definition of research. Further IRB review is not required. Ensure that all those associated with the project are aware that it is ongoing. In future publications/presentations, it is recommended you refer to this as QA/QI and not as research. Adopted with permission from the University of Wisconsin Health Sciences IRB. * If an approval is required to publish, it is a requirement to submit an IRB application prior to initiation of the project. No retroactive approvals will be provided. ** Forms available at http://www.uccs.edu/osp/research-compliance/research-involving-human-subject-irb.html#forms

Human Subject Worksheet The University of Colorado Colorado Springs (UCCS) requires that all research involving human subjects conducted by faculty, staff, or students affiliated with the university, be reviewed and approved by the Institutional Review Board (IRB) prior to initiation, regardless of the source of funding and regardless of its federal status as an exempt, an expedited, or a full review project. The purpose of this worksheet is to provide support for individual in determine whether an activity is Human Subject Research or how it is regulated. This worksheet is to be used and does not need to be completed, submitted, or retained. 1 Research as Defined by DHHS Regulations (Check if Yes.) Is the activity an investigation? (Investigation: A searching inquiry for facts; detailed or careful examination.) Is the investigation systematic? (Systematic: Having or involving a system, method, or plan.) Is the systematic investigation designed to develop or contribute to knowledge? (Designed: Observable behaviors used to develop or contribute to knowledge. Develop: To form the basis for a future contribution. Contribute: To result in. Knowledge: Truths, fact, information.) Is the knowledge the systematic investigation is designed to develop or contribute generalizable? (Generalizable: Universally or widely applicable. 2 Human Subject under DHHS Regulations (Check if Yes.) Is the investigator conducting the Research gathering data about living individuals 3 Human Subject Under DHHS Regulations (Check if Yes.) Will the investigator gather that data through either of the following mechanisms (Specify which mechanism(s) apply): Physical procedures or manipulations of those individuals or their environment for research purposes ( intervention ). Communication or interpersonal contact with the individuals. ( interaction ). 4 Human Subject Under DHHS Regulations (Check if Yes ). Will the investigator gather data that is either? (Specify which category(s) apply): The data are about behavior that occurs in a context in which an individual can reasonably expect that no observation or recording is taking place (i.e. Private information ). Individuals have provided the data for specific purposes in which the individuals can reasonably expect that it will T be made public, such as a medical record (i.e. Private information ). Can the individuals identifies be readily ascertained or associated with the information by the investigator (i.e. identifiable information )? If any items are checked under 1,2, and 3 or 1, 2, and 4, the activity is Human Research under DHHS regulations 5 Human Research Under FDA Regulations (Check if Yes.) Does the activity involve any of the following? (Check all that apply) In the United States: The use of a drug i in one or more persons other than use of an approved drug in the course of medical practice. In the United States: the use of a device ii in one or more persons that evaluates the safety or effectiveness of that device. Data regarding subjects or control subjects submitted to or held for inspection by FDA iii. Data regarding the use of a device on human specimens (identified or unidentified) submitted to or held for inspection by FDA iv. If Yes, the activity is Human Research under FDA regulations If the activity is Human Research under DHHS regulations or under FDA regulations, it is Human Research under UCCS policy. i The term drug means: (A) Articles recognized in the official United States Pharmacopoeia, Official Homoeopathic Pharmacopoeia of the United States, or official National Formulary, or any supplement to any of them; and (B) Articles intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in man or other animals; and (C) Articles (other than food and dietary supplements) intended to affect the structure or any function of the body of man or other animals; and (D) Articles intended for use as a component of any article specified in clause (A), (B), or (C) ii The term device means an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or relate article, including any component, part or accessory, which is: (1) Recognized in the official National Formulary, or the United States Pharmacopeia, or any supplement to them, (2) Intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease, in man or other animals, or (3) Intended to affect the structure or any function of the body of man or other animals, and which does not achieve its primary intended purposes through chemical action within or on the body of man or other animals and which is not dependent upon being metabolized for the achievement of its primary intended purposes. iii This is specific to submissions that are part of an application for a research or marketing permit. However, unless otherwise indicated, assume all submissions to FDA meet this requirement. iv This is specific to submissions that are part of an application for a research or marketing permit. However, unless otherwise indicated, assume all submissions to FDA meet this requirement.

New IRB Application Review Process application with applicable addendums conducts pre-review and assigns reviewer Reviewer sends revision requirements to PI, if applicable revisions to irb@uccs.edu* Risk level is assigned Reviewer reviews revisions for accuracy processes revisions and forwards to reviewer Exempt Determination Expedited Determination Full Review Determination and on agenda for next IRB board meeting completes final processing and notifies PI Reviewer completes review and forwards to Revisions requested, if needed. completes final processing and notifies PI Application is disapproved Reviewer reviews revisions for accuracy and sends for re-review processes revisions and forwards to reviewer revisions to irb@uccs.edu* IRB Chair informs PI of required revisions Application is tabled until next meeting Reviewer reviews revisions for accuracy and forwards approval processes revisions and forwards to reviewer revisions to irb@uccs.edu* IRB Chair informs PI of required revisions Application approved with changes completes final processing and notifies PI Application approved as submitted * If the PI is a student, the application must be submitted via the faculty advisor s email address. Revisions can be sent to the IRB by the student, with the faculty advisor being carbon copies (cc d).